SARS-CoV-2 rebound with and without antivirals
Lancet Infect Dis
.
2023 Jun;23(6):637-639.
doi: 10.1016/S1473-3099(23)00063-4.
Epub 2023 Feb 13.
Author
Nicola Petrosillo
1
Affiliation
1
Infection Prevention and Control-Infectious Disease Service, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy. Electronic address: n.petrosillo@policlinicocampus.it.
PMID:
36796396
PMCID:
PMC9925057
DOI:
10.1016/S1473-3099(23)00063-4
No abstract available
Publication types
Comment
MeSH terms
Antiviral Agents / pharmacology
Antiviral Agents / therapeutic use
COVID-19*
Dermatologic Agents*
Humans
SARS-CoV-2
Virus Replication
Substances
Antiviral Agents
Dermatologic Agents